Every year, CPG companies optimize their manufacturing. They cut defect rates, compress plant cycle times and tighten ...
De Novo FDA submission for moderate-to-severe insomnia HOUSTON, TX, April 22, 2026 (GLOBE NEWSWIRE)-- Nexalin Technology, Inc ...
The anti-science movement’s obsession with peptides undermines evidence-based medicine and will inevitably lead to worse ...
10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.
Hydreight (HYDTF) has transformed into a 50-state healthcare infrastructure company, rapidly scaling VSDHOne licenses to 11K+ ...
Nexalin Technology, Inc. (Nasdaq: NXL) (the "Company" or "Nexalin"), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS) of the brain ...
A little over a year after reabsorbing its anticoagulant abelacimab, Novartis has now terminated two phase 3 trials for the ...
The EU Health Technology Assessment (HTA) Regulation, which began phasing in from January 2025, introduced a new Joint Clinical Assessment (JCA) process to streamline and harmonize the comparative ...
Seventeen placebo-controlled trials across seven antibodies yielded statistically significant but clinically small mean ...
Voters cast ballots on a state constitutional amendment that would pave the way for a new congressional map designed to help ...
Target identification is the first and perhaps most critical step in drug discovery and development. Although the human genome contains roughly 20,000 protein-coding genes, only about 4,500 are ...
Secretary of the Navy John Phelan was fired on Wednesday after months of infighting with senior Pentagon leaders, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results